Abstract | OBJECTIVE: METHODS: In a randomized, placebo-controlled trial, infected children were randomly assigned to treatment with albendazole + placebo, ivermectin + placebo, diethylcarbamazine + placebo, albendazole + ivermectin, or albendazole + diethylcarbamazine. The Kato-Katz method was used for qualitative and quantitative parasitological diagnosis. The chi2 test was used to determine the significance of cure rates, repeated measures analysis of variance for the comparison of mean log egg counts, the Newman-Keuls procedure for multiple comparison tests, and logistic regression for the comparison of infection rates at days 180 and 360 after treatment. FINDINGS: CONCLUSION:
|
Authors | V Y Belizario, M E Amarillo, W U de Leon, A E de los Reyes, M G Bugayong, B J C Macatangay |
Journal | Bulletin of the World Health Organization
(Bull World Health Organ)
Vol. 81
Issue 1
Pg. 35-42
( 2003)
ISSN: 0042-9686 [Print] Switzerland |
PMID | 12640474
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anthelmintics
- Placebos
- Ivermectin
- Albendazole
- Diethylcarbamazine
|
Topics |
- Adolescent
- Albendazole
(administration & dosage, therapeutic use)
- Anthelmintics
(administration & dosage, therapeutic use)
- Ascariasis
(drug therapy)
- Child
- Diethylcarbamazine
(administration & dosage, therapeutic use)
- Drug Therapy, Combination
- Humans
- Ivermectin
(administration & dosage, therapeutic use)
- Philippines
- Placebos
- Single-Blind Method
- Treatment Outcome
- Trichuriasis
(drug therapy)
|